Compare VVPR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVPR | IRIX |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 25.4M |
| IPO Year | 2016 | 1996 |
| Metric | VVPR | IRIX |
|---|---|---|
| Price | $2.10 | $1.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 987.6K | 114.0K |
| Earning Date | 09-02-2023 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $61,000.00 | ★ $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | $8.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 281.25 | 4.58 |
| 52 Week Low | $0.62 | $0.78 |
| 52 Week High | $8.88 | $1.65 |
| Indicator | VVPR | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 54.59 |
| Support Level | $1.23 | $1.35 |
| Resistance Level | $1.49 | $1.52 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 43.52 | 37.58 |
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.